EyePoint Plc (EYPT)
15.99
-0.11
(-0.68%)
USD |
NASDAQ |
Dec 12, 16:00
15.98
0.00 (0.00%)
After-Hours: 20:00
EyePoint Research and Development Expense (Quarterly): 47.75M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 217.13M |
| Agios Pharmaceuticals, Inc. | 85.42M |
| Viking Therapeutics, Inc. | 89.95M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 2.526M |